Skip to main content
Log in

Mohs micrographic surgery cost effective for stage T2a cutaneous squamous cell carcinoma

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Brigham and Women's Hospital Tumour Classification System

Reference

  • Udkoff J, et al. Cost Effectiveness of Intermediate-Risk Squamous Cell Carcinoma Treated with Mohs Micrographic Surgery Compared with Wide Local Excision. Journal of the American Academy of Dermatology : 4 Aug 2021. Available from: URL: http://doi.org/10.1016/j.jaad.2021.07.059

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohs micrographic surgery cost effective for stage T2a cutaneous squamous cell carcinoma. PharmacoEcon Outcomes News 885, 15 (2021). https://doi.org/10.1007/s40274-021-07957-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-07957-x

Navigation